Questions discussed in this category

My understanding is that this risk is exceedingly rare even with treatment in and around the stalk and hypothalamus. 

Does it matter whether the intracranial lesions have been treated with whole brain or SRS/SRT?

Papers discussed in this category

Neuro-oncology, 2011 Jun 10

The Journal of clinical endocrinology and metabolism, 2001-12

J. Clin. Endocrinol. Metab.,

J. Clin. Endocrinol. Metab.,


Metab. Clin. Exp.,

J. Neurosurg., 2018 Nov 09

Clin Endocrinol (Oxf), 2009 Jul 24

Nat Clin Pract Endocrinol Metab,

Neurosurgery, 2008-01

Clinical neurology and neurosurgery, 2013-02

Ann. Endocrinol. (Paris),

Ann. Endocrinol. (Paris), 2013 Nov 25